Infografica: Cermed internazionale – opportunità di investimento

5luglio 2011 / Infografica / I commenti sono disabilitati

CerMed internazionale (telescrivente: GMS).

Scarica Infografica Cermed (PDF)

What it does:

CerMed’s mission is to improve the health of women worldwide by providing quality, high-value medical products that aid in the detection of female reproductive diseases.

Core products and services:

 1. The CerScreen system is a Point-of-Care approach a woman can do in the comfort of her home in just a few minutes, replace the laboratory Pap test, which is a form of cervical cancer screening.

Approx. 160 milione Pap Smear procedures are performed annually worldwide, which translates into solo 20% of the target population being serviced.This offers a market opportunity to promote a product that replaces the Pap Test. The predicted market expansion is $20 miliardo.

 2. CerMed has developed CerCap, a single use women’s medical device that reduces the risk of both contracting HIV/AIDS and conception.

The product is developed for Women’s Controlled Contraception and HIV/AIDS Protection:

• 33 milioni di persone are living with HIV/AIDS

• 2.7 million new cases are reported per year, oltre 50% in women.

The product has a $40 Billion market potential for the developing world.

Complessivo:

CerMed offers two innovative products that can cambiare a woman’s life for the better. The products are revolutionary to a certain extent. Il first product is a system developed to replace the classical Pap Test, which  detects cervical cancer. The pap test has limited informational value and is far from being a perfect solution. Il second product is a contraceptive, anti-HIV/AIDS drug. CerMed plans to offer the drug in the developing world, where a $40+ billion sales potential exists, combined with the first product mentioned, CerMed anticipates a $60 miliardo sales projection.

LittleSkylark

Tags: advice infographic investimento stock